Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Tack

Showing results (41-50 of 644) with videos related to

Pageof 65
Sort By:
Expert Opinion on Pharmacotherapy|August 2, 2002
Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndromeMaura Corsetti, Jan Tack
Current Opinion in Gastroenterology|September 15, 2010
Gastroduodenal motilityJan Tack, Pieter Janssen
Gastroenterology Clinics of North America|July 16, 2003
Functional dyspepsia: evaluation and treatmentMagnus Simrén, Jan Tack
Best Practice & Research. Clinical Gastroenterology|December 21, 2025
From pathophysiology to practice: Dietary strategies for gastrointestinal disordersTim Vanuytsel, Jan Tack
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2012
Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipationJan Tack, Maura Corsetti
Gastroenterology|December 4, 2004
Mechanisms underlying meal-induced symptoms in functional dyspepsiaJan Tack, Raf Bisschops
Digestive Diseases (Basel, Switzerland)|May 9, 2008
Pathogenesis of dyspepsiaKostas Mimidis, Jan Tack
Current Opinion in Pharmacology|September 25, 2018
New developments in the treatment of gastroparesis and functional dyspepsiaJan Tack, Michael Camilleri
Expert Opinion on Investigational Drugs|October 17, 2008
Renzapride: a new drug for the treatment of constipation in the irritable bowel syndromeEmidio Scarpellini, Jan Tack
Alimentary Pharmacology & Therapeutics|July 26, 2022
Editorial: refractory reflux sensitivity-A place for baclofen? Authors' replyKarlien Raymenants, Jan Tack
Pageof 65

Showing results (41-50 of 644) with videos related to

Sort By:
Pageof 65
Expert Opinion on Pharmacotherapy|August 2, 2002
Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndromeMaura Corsetti, Jan Tack
Current Opinion in Gastroenterology|September 15, 2010
Gastroduodenal motilityJan Tack, Pieter Janssen
Gastroenterology Clinics of North America|July 16, 2003
Functional dyspepsia: evaluation and treatmentMagnus Simrén, Jan Tack
Best Practice & Research. Clinical Gastroenterology|December 21, 2025
From pathophysiology to practice: Dietary strategies for gastrointestinal disordersTim Vanuytsel, Jan Tack
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2012
Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipationJan Tack, Maura Corsetti
Gastroenterology|December 4, 2004
Mechanisms underlying meal-induced symptoms in functional dyspepsiaJan Tack, Raf Bisschops
Digestive Diseases (Basel, Switzerland)|May 9, 2008
Pathogenesis of dyspepsiaKostas Mimidis, Jan Tack
Current Opinion in Pharmacology|September 25, 2018
New developments in the treatment of gastroparesis and functional dyspepsiaJan Tack, Michael Camilleri
Expert Opinion on Investigational Drugs|October 17, 2008
Renzapride: a new drug for the treatment of constipation in the irritable bowel syndromeEmidio Scarpellini, Jan Tack
Alimentary Pharmacology & Therapeutics|July 26, 2022
Editorial: refractory reflux sensitivity-A place for baclofen? Authors' replyKarlien Raymenants, Jan Tack
Pageof 65